Related Experiment Video
Updated: Dec 27, 2025
03:01
Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity
Published on: August 2, 2024
1.6K
Ectopic pregnancy and its long-term results
Alla V Boychuk1, Oksana I Khlibovska1, Yuliia B Yakymchuk1
1I.Horbachevsky Ternopil National Medical University, Ternopil, Ukraine.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|March 4, 2020
Summary
Medical treatment for ectopic pregnancy preserves fallopian tube patency better than surgery. This leads to improved reproductive outcomes, reducing infertility rates associated with surgical interventions like laparotomy.
Area of Science:
- Reproductive Medicine
- Gynecologic Surgery
- Pharmacologic Therapy
Background:
- Ectopic pregnancy diagnosis and treatment have evolved significantly.
- Historically, surgical interventions like laparotomy were standard.
- Conservative management options are increasingly utilized.
Purpose of the Study:
- To evaluate long-term reproductive outcomes after ectopic pregnancy treatment.
- To compare surgical versus medical management regarding fallopian tube patency.
- To assess the incidence of subsequent uterine pregnancies.
Main Methods:
- Retrospective analysis of 615 ectopic pregnancy cases.
- Prospective examination of 140 patients in three treatment groups: laparotomy, laparoscopy, and methotrexate.
- Data collected from patient medical records.
Main Results:
- Laparotomy rates decreased from 86.88% (2005) to 18.92% (2015).
- Methotrexate use increased to 51.35% by 2015.
- Medical treatment showed significantly better fallopian tube patency compared to surgical methods.
Conclusions:
- Medical management with methotrexate offers superior fallopian tube patency.
- Laparotomy with tubectomy results in tubal infertility in 60% of cases.
- Delayed diagnosis in 2005 led to increased urgent laparotomies over conservative treatments.
Related Concept Videos
01:27Ovarian Cycle
3.1K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
3.1K
01:07Teratogenicity
3.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
02:07Oogenesis
68.6K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
68.6K